{
    "title": "SCENAR: Self-Controlled Energo-Neuro-Adaptive Regulation",
    "inventor_name": "Alexandr A. Karasev",
    "publication_year": null,
    "device_name": "SCENAR",
    "goal": "Provide a portable, non-invasive therapeutic method that stimulates the nervous system to induce endogenous neuropeptide release and promote healing across a wide range of medical conditions.",
    "problem_addressed": "The need for a lightweight, energy-efficient medical treatment for space travel and general healthcare that avoids the logistical and toxic drawbacks of storing and using many pharmaceuticals.",
    "concept_summary": "SCENAR is a hand-held biofeedback device that delivers a series of adaptive electrical impulses through skin electrodes. The device measures the skin's electrical response and modifies subsequent signals, targeting C-fibres to trigger the body's own production of regulatory neuropeptides, which are claimed to restore physiological balance and accelerate healing.",
    "detailed_description": "The device weighs ~300 g, is ~200 mm long and runs on a 9 V battery. One end contacts the skin while the other contains electronics that generate high-amplitude, variable-frequency electrical pulses. Each pulse is emitted only after a change in skin resistance is detected, creating a feedback loop. The stimulation is said to activate C-fibres (~=85 % of peripheral nerves), prompting the release of neuropeptides and other regulatory peptides that act systemically. Practitioners monitor skin responses such as redness, numbness, stickiness, or changes in a numeric display, and adjust treatment locations accordingly. The therapy is applied repeatedly (daily for acute conditions, several times a week for chronic) and is claimed to be safe for most patients except those with cardiac pacemakers.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Biofeedback-controlled electrical stimulation",
        "Adaptive signal modulation based on skin resistance",
        "Targeted activation of C-fibres",
        "Induction of endogenous neuropeptide release"
    ],
    "scientific_domains": [
        "Medicine",
        "Physiology",
        "Neuroscience",
        "Bioelectromagnetics"
    ],
    "mechanisms_of_action": [
        "Electrical stimulation of peripheral nerves (C-fibres)",
        "Skin-based biofeedback loop to tailor pulse parameters",
        "Triggering of endogenous peptide cascades for immune and metabolic regulation"
    ],
    "materials": [
        "Metal electrodes",
        "Plastic housing",
        "9 V alkaline battery"
    ],
    "energy_sources": [
        "9 V battery (electrical)"
    ],
    "inputs": [
        "Skin electrical resistance measurements",
        "Patient-specific treatment protocol"
    ],
    "outputs": [
        "Variable electrical impulses",
        "Physiological response (skin redness, tingling)",
        "Release of neuropeptides (biological output)"
    ],
    "claimed_performance": "Effective in ~80 % of treated cases; full recovery in ~66 % of those, significant improvement in the remainder. Reported superior pain relief compared with administered opiates and reduced recovery times for injuries and postoperative patients.",
    "experimental_evidence": "Russian clinical reports cite >50 000 treatment cases and ~600 practitioners using the device. The British Standards Institute has licensed it for pain relief. No peer-reviewed randomized trials are presented in the article.",
    "replication_status": "In use by ~600 Russian practitioners; licensed in the UK for pain-relief applications; multiple commercial models produced by OKB Ritm and LET Medical.",
    "keywords": [
        "biofeedback",
        "electro-stimulation",
        "C-fibres",
        "neuropeptide",
        "pain relief",
        "immune modulation",
        "portable medical device"
    ],
    "related_technologies": [
        "TENS (Transcutaneous Electrical Nerve Stimulation)",
        "Electroacupuncture",
        "Neurostimulation devices",
        "Biofeedback monitoring systems"
    ],
    "controversy_level": "high",
    "confidence_score": 0.73,
    "practicability_score": 0.81,
    "fringe_score": 0.68,
    "evidence_strength": 0.52,
    "risk_score": 0.22,
    "trl_estimate": 7,
    "source_urls": [
        "http://www.scenar.info/",
        "http://www.scenar-revenko.ru",
        "http://www.alternative-doctor.com/specials/scenar.htm"
    ],
    "organizations": [
        "Priboy Company",
        "OKB Ritm",
        "LET Medical",
        "Sochi University"
    ],
    "applications": [
        "Pain management",
        "Accelerated wound healing",
        "Immune system support",
        "Recovery from sports injuries",
        "Adjunct therapy for cardiovascular, respiratory, and neurological disorders"
    ],
    "limitations": [
        "Lack of controlled, peer-reviewed clinical trials",
        "Broad, non-specific efficacy claims",
        "Contraindicated for patients with cardiac pacemakers",
        "Reliance on practitioner skill for electrode placement"
    ],
    "open_questions": [
        "What is the quantitative relationship between stimulation parameters and neuropeptide release?",
        "How does the device compare to standard therapies in randomized controlled studies?",
        "What are the long-term safety effects of repeated high-amplitude stimulation?",
        "Can the claimed 80 % efficacy be independently verified?"
    ],
    "red_flags": [
        "Extraordinary claims of treating virtually all diseases without rigorous scientific validation",
        "Anecdotal evidence predominates over peer-reviewed data",
        "Potential for placebo effect and bias in uncontrolled case series"
    ],
    "evidence_quotes": [
        "Tests conducted in Russia have since shown the Scenar is proves effective in 80% of cases.",
        "In Russia, there are over 50,000 cases of the device's use and some 600 practitioners currently use the device as their principal treatment instrument.",
        "The British Standards Institute has licensed the device for pain relief only.",
        "The device sends out a series of signals through the skin and measures the response. Each signal is only sent out when a change, in response to the previous signal, is recorded in the electrical properties of the skin.",
        "Both cancer and fracture patients have found more pain relief from the release of natural opoids after scenar treatment than from administered opiates."
    ]
}